Latest news
Oramed Pharmaceuticals (NASDAQ:ORMP) Releases Quarterly Earnings Results - MarketBeatMarketBeat · Mon, 10 Aug 2026 22:28:04 GMTOramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview - TradingViewTradingView · Mon, 10 Aug 2026 21:58:04 GMTOramed: Q2 Earnings Snapshot - KTVBKTVB · Mon, 10 Aug 2026 21:39:00 GMTORAMED PHARMACEUTICALS INC. 2Q 2026: Revenue $0 Net income $78.16M, EPS $1.84— 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 21:31:03 GMTOramed Pharmaceuticals (NASDAQ: ORMP) pivots to investment model with $116M profit - stocktitan.netstocktitan.net · Mon, 10 Aug 2026 21:30:27 GMTOramed Pharmaceuticals Inc (ORMP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 19:37:21 GMTOramed Pharmaceuticals (ORMP) Projected to Release Quarterly Earnings on Thursday - MarketBeatMarketBeat · Thu, 06 Aug 2026 13:36:41 GMTOramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Above 200 Day Moving Average - What's Next? - MarketBeatMarketBeat · Thu, 06 Aug 2026 09:24:01 GMT